Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Triosephosphate isomerase 1 pseudogene 3 (TPI1P3) is a processed pseudogene found in the human genome. Unlike its parent gene TPI1, which encodes a critical glycolytic enzyme involved in energy metabolism, TPI1P3 contains sequence homology to TPI1 but is nonfunctional, lacking the ability to produce an active protein[1][7]. Processed pseudogenes arise via retrotransposition, where a copy of the mRNA of a functional gene is reverse-transcribed and inserted elsewhere in the genome, typically without introns, promoters, or regulatory elements necessary for proper expression[4]. TPI1P3, like other pseudogenes, does not participate in biological processes, does not have established roles in disease, and is not a therapeutic target[1][5][7]. There is no evidence for protein-coding capability, disease association, drug interaction, or use as a clinical biomarker[1][2][7]. Any references to function or disease relate to the parent gene TPI1, not to TPI1P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Triosephosphate isomerase 1 pseudogene 3 (TPI1P3).